Transmembrane prolyl 4 hydroxylase market is anticipated to grow at a significant CAGR during the forecast period. Transmembrane prolyl 4-hydroxylase (P4H-TM) is a member of the P4H family. Additionally, biallelic loss of function P4H-TM mutations causes a syndromic form of severe cognitive impairment in humans. The major factor driving the demand for transmembrane prolyl 4 hydroxylase market is the increasing prevalence of colitis across the globe. 

According to the National Center for Biotechnology Information (NCBI), ulcerative colitis has an incidence rate of 9 to 20 cases per 100,000 persons per year globally. Additionally, its prevalence is 156 to 291 cases per 100,000 persons per year across the globe. Furthermore, it has a greater prevalence in adults compared to Crohn's disease. Hence, the increasing prevalence of colitis is driving the demand for transmembrane prolyl 4 hydroxylase. 

Moreover, North America hold a prominent share in the market owing to the presence of an advanced healthcare infrastructure as well as the presence of key players in the region. Additionally, the market is also growing due to the increasing application of transmembrane prolyl 4 hydroxylase in several diseases such as inflammatory bowel disease, among others. Some major players in the market include Astellas Pharma Inc., and GlaxoSmithKline Plc, among others.  

To Request a Sample of our Report on Transmembrane Prolyl 4 Hydroxylase Market:  https://www.omrglobal.com/request-sample/transmembrane-prolyl-4-hydroxylase-market

Market Coverage

·        The market number available for – 2022-2030

·        Base year- 2022

·        Forecast period- 2023-2030

Segment Covered- 

·        By Type

·        By Application

Regions Covered-

·        North America

·        Europe

·        Asia-Pacific

·        Rest of the World

Competitive Landscape- Astellas Pharma Inc., and GlaxoSmithKline Plc, among others. 

Transmembrane Prolyl 4 Hydroxylase Market Report by Segment

By Type

•             Daprodustat

•             Dimethyloxalylglycine

•             FG-22216

•             FG-4497

•             Others

By Application

•             Anemia

•             Inflammatory Bowel Dosease

•             Brain

•             Edema

•             Colitis

•             Others

A full Report of Transmembrane Prolyl 4 Hydroxylase Market is Available @ https://www.omrglobal.com/industry-reports/transmembrane-prolyl-4-hydroxylase-market

Transmembrane Prolyl 4 Hydroxylase Market Report by Region

North America

·        United States

·        Canada

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan

·                  South Korea

·                  Rest of APAC

Rest of the World

·        Latin America 

·        Middle East & Africa

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no:  +91 7803040404